Targeted Radionuclide Therapy with A (177)Lu-labeled Anti-HER2 Nanobody

RIT has become an attractive strategy in cancer treatment, but still faces important drawbacks due to poor tumor penetration and undesirable pharmacokinetics of the targeting vehicles. Smaller radiolabeled antibody fragments and peptides feature highly specific target accumulation, resulting in low...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: D'Huyvetter, Matthias, Vincke, Cécile, Xavier, Catarina, Aerts, An, Impens, Nathalie, Baatout, Sarah, De Raeve, Hendrik, Muyldermans, Serge, Caveliers, Vicky, Devoogdt, Nick, Lahoutte, Tony
Формат: Artigo
Язык:Inglês
Опубликовано: Ivyspring International Publisher 2014
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4038753/
https://ncbi.nlm.nih.gov/pubmed/24883121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.8156
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы